Skip to main content
How strong is your knowledge on continuous glucose monitors? Take the quiz to test your expertise!
>
HIV Management
Resource Center
Menu
Menu
Main navigation
Home
Education
Featured Topics
Acute Hepatic Porphyria
Agitation in Alzheimer Disease
Alzheimer Disease
COVID-19
Depression Care 360
Diabetes
Diabetes Technology
Digital Health Solutions in Diabetes
Dry Eye Disease
Endometrial Cancer
GSK Partner Spotlight
HIV Management
MASH
Nephropathic Cystinosis
Neuromyelitis Optica Spectrum Disorder
Pain Management
Type 2 Diabetes
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Multidisciplinary Roundtables
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Publication
About Consultant
Advertising With Consultant360
Author Guidelines
Call for Papers
Case Report Templates
Consultant Current Issue
Consultant Archive
Consultant Early View
FAQ
Get Permissions
Job Board
Get Permissions
Search
Contact
Login
Menu
Menu
Main navigation
Home
Education
Featured Topics
Acute Hepatic Porphyria
Agitation in Alzheimer Disease
Alzheimer Disease
COVID-19
Depression Care 360
Diabetes
Diabetes Technology
Digital Health Solutions in Diabetes
Dry Eye Disease
Endometrial Cancer
GSK Partner Spotlight
HIV Management
MASH
Nephropathic Cystinosis
Neuromyelitis Optica Spectrum Disorder
Pain Management
Type 2 Diabetes
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Multidisciplinary Roundtables
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Publication
About Consultant
Advertising With Consultant360
Author Guidelines
Call for Papers
Case Report Templates
Consultant Current Issue
Consultant Archive
Consultant Early View
FAQ
Get Permissions
Job Board
Get Permissions
Viral Infections
Poll: HIV Viral Suppression
Copied to clipboard
<section><h2><h2><p>In a recent study, researchers aimed to examine the number of children, adolescents, and adults with HIV who are taking antiretroviral therapy and have achieved viral suppression at 1, 2, and 3 years after initiation of treatment. They found that adults are approaching the global target of 95% viral suppression, but children and adolescents are not. In your opinion, how can children and adolescents achieve this target?</p><p> </p></h2></h2></section><section><h2><h2></h2><h2><p>In a <a href="https://consultant360.com/index.php/exclusive/consultant360/hiv-management/children-adolescents-hiv-are-achieving-viral-suppression" target="_blank">recent study</a>, researchers aimed to examine the number of children, adolescents, and adults with HIV who are taking antiretroviral therapy and have achieved viral suppression at 1, 2, and 3 years after initiation of treatment. They found that adults are approaching the global target of 95% viral suppression, but children and adolescents are not. In your opinion, how can children and adolescents achieve this target?</p></h2></h2></section><section><h2><h2><strong>Thank you for your response! For more HIV management content, visit our <a href="https://www.consultant360.com/specialty/infectious-diseases/hiv-management" target="_blank">Resource Center</a>.</strong></h2></h2></section>
